Next Article in Journal
Multivalent Neuroprotective Activity of Elettaria cardamomum (Cardamom) and Foeniculum vulgare (Fennel) in H2O2-Induced Oxidative Stress in SH-SY5Y Cells and Acellular Assays
Previous Article in Journal
Breath and Beyond: Advances in Nanomedicine for Oral and Intranasal Aerosol Drug Delivery
Previous Article in Special Issue
Drug–Drug Interactions between Tamsulosin and Mirabegron in Healthy Individuals Do Not Affect Pharmacokinetics and Hemodynamic Parameters Significantly
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 18
Issue 1
10.3390/ph18010001
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceuticals 2022, 15(11), 1400.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: AlRasheed et al. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals 2022, 15, 1400

by
Hajer AlRasheed
1,†,
Aliyah Almomen
1,*,†,
Haya I. Aljohar
1,
Maria Arafah
2,
Rana Y. Almotawa
1,
Manal A. Alossaimi
3 and
Nourah Z. Alzoman
1
1
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia
2
Department of Pathology, College of Medicine, King Saud University, P.O. Box 2925, Riyadh 11421, Saudi Arabia
3
Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdelaziz University, P.O. Box 173, Alkharj 11942, Saudi Arabia
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Pharmaceuticals 2025, 18(1), 1; https://doi.org/10.3390/ph18010001
Submission received: 5 November 2024 / Accepted: 21 November 2024 / Published: 24 December 2024
(This article belongs to the Special Issue Pharmacokinetics (PK)/Pharmacodynamics (PD) Study in Drug Discovery and Development)
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in Figure 5: There was no drastic change in body weight between day 0 and day 1. Day 0 data were entered mistakenly as zero instead of the actual weight prior to administration. The text on the y axis of the graph should have indicated body weight and not % body weight. The corrected Figure 5 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Pharmaceuticals 18 00001 i001

Reference

  1. AlRasheed, H.; Almomen, A.; Aljohar, H.I.; Arafah, M.; Almotawa, R.Y.; Alossaimi, M.A.; Alzoman, N.Z. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals 2022, 15, 1400. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

AlRasheed, H.; Almomen, A.; Aljohar, H.I.; Arafah, M.; Almotawa, R.Y.; Alossaimi, M.A.; Alzoman, N.Z. Correction: AlRasheed et al. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals 2022, 15, 1400. Pharmaceuticals 2025, 18, 1. https://doi.org/10.3390/ph18010001

AMA Style

AlRasheed H, Almomen A, Aljohar HI, Arafah M, Almotawa RY, Alossaimi MA, Alzoman NZ. Correction: AlRasheed et al. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals 2022, 15, 1400. Pharmaceuticals. 2025; 18(1):1. https://doi.org/10.3390/ph18010001

Chicago/Turabian Style

AlRasheed, Hajer, Aliyah Almomen, Haya I. Aljohar, Maria Arafah, Rana Y. Almotawa, Manal A. Alossaimi, and Nourah Z. Alzoman. 2025. "Correction: AlRasheed et al. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals 2022, 15, 1400" Pharmaceuticals 18, no. 1: 1. https://doi.org/10.3390/ph18010001

APA Style

AlRasheed, H., Almomen, A., Aljohar, H. I., Arafah, M., Almotawa, R. Y., Alossaimi, M. A., & Alzoman, N. Z. (2025). Correction: AlRasheed et al. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals 2022, 15, 1400. Pharmaceuticals, 18(1), 1. https://doi.org/10.3390/ph18010001

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop